title: Editorial comment.
authors: Department of Urology, Assaf Harofeh Medical Center, Zerifin, Israel.
authors: Amnon
authors: A
authors: Zisman
mesh_terms: D058891:5-alpha Reductase Inhibitors / Q000008:administration & dosage*; D058668:Adrenergic alpha-1 Receptor Antagonists / Q000008:administration & dosage*; D001378:Azasteroids / Q000008:administration & dosage*; D017292:Doxazosin / Q000008:administration & dosage*; D000068538:Dutasteride; D006801:Humans; D059411:Lower Urinary Tract Symptoms / Q000209:etiology*; D008297:Male; D011470:Prostatic Hyperplasia / Q000150:complications* / Q000188:drug therapy*
chemical_list: D058891:5-alpha Reductase Inhibitors; D058668:Adrenergic alpha-1 Receptor Antagonists; D001378:Azasteroids; D017292:Doxazosin; D000068538:Dutasteride